Froedtert & MCW health network is part of the National Institutes of Health All of Us Research Program. It has a simple mission — speed up health research breakthroughs. Learn how you can help make a difference by joining the All of Us Research Program.
Displaying 81 - 90 of 261
A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH) (ROAR)
A Phase 1, First-in-human, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-1454
Ablation with Confirmation of Colorectal Liver Metastases (ACCLAIM) Prospective Trial for Microwave Ablation as a Local Cure
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM)
Satralizumab in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder
Impact of EMST on Swallowing Function in Head/Neck Ca Pts Undergoing Radiotherapy +/- Chemotherapy
Testing olaparib and temozolomide versus the usual treatment for uterine leiomyosarcoma after chemotherapy has stopped working
BCMA Directed CAR-T Cells in Relapsed And Or Refractory Multiple Myeloma
To characterize the safety and tolerability of talquetamab when administered in different combination regimens.
A Phase 1b/2 Study to Evaluate TTI-101 in Participants with HCC